Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 5, 2000, Pages 389-396

  Hsueh, Chung Tsen ^a   Chiu, Chang Fang ^a   Kelsen, David P ^b   Schwartz, Gary K ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bcl 2; Gene expression; Phorbol esters; Protein kinase C; Safingol

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CYCLOOXYGENASE 2; MESSENGER RNA; MITOMYCIN C; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; PROTEIN KINASE C; SAFINGOL;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0034005928     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051007     Document Type: Article

References (64)

1. 3H]thymidine incorporation assay. J Immunol Methods 170: 211
2. 2. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA (1999) Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 274: 7545
3. 3. Blanco A, Habib A, Levy-Toledano S, Maclouf J (1995) Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem J 312: 419
4. 4. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ (1999) Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59: 991
5. 5. Chen-Levy Z, Nourse J, Cleary ML (1989) The Bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14, 18) translocation. Mol Cell Biol 9: 701
6. 6. Chida M, Voelkel NF (1996) Effects of acute and chronic hypoxia on rat lung cyclooxygenase. Am J Physiol 270: L872
7. 7. Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD (1997) Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A 94: 657
8. 8. Danso D, Farsi K, Greaney C, Spriggs D, Kelsen DK, Schwartz GK (1997) The protein kinase C inhibitor safingol restores mitomycin-C-induced loss of PKCα and PKC∈ expression in association with the induction of apoptosis. Proc Am Assoc Cancer Res 38: A1305
9. 9. Dean JLE, Brook M, Clark AR, Saklatvala J (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274: 264
10. 10. DuBois RN, Radhika A, Reddy BS, Entingh AJ (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259
11. 11. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Vandeputte LBA, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12: 1063
12. 12. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183
13. 13. Evett GE, Xie W, Chipman JG, Robertson DL, Simmons DL (1993) Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes. Arch Biochem Biophys 306: 169
14. 14. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55
15. 15. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, Kolesnick RN (1994) Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525
16. 16. Han YQ, Meng T, Murray NR, Field AP, Brasier AR (1999) Interleukin-1-induced nuclear factor-kappa B-I kappa B alpha autoregulatory feedback loop in hepatocytes - a role for protein kinase C alpha in post-transcriptional regulation of I kappa B alpha resynthesis. J Biol Chem 274: 939
17. 17. Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, New York
18. 18. Herschman HR (1996) Prostaglandin synthase 2. Biochim Biophys Acta 1299: 125
19. 19. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T (1998) Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58: 3761
20. 20. Hsueh CT, Dolnick BJ (1994) Regulation of folate-binding protein gene expression by DNA methylation in methotrexate-resistant KB cells. Biochem Pharmacol 47: 1019
21. 21. Hsueh C-T, Kelsen D, Schwartz GK (1998) UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. Clin Cancer Res 4: 2201
22. 22. Hughes FJ, Buttery LDK, Hukkanen MVJ, O'Donnell A, Maclouf J, Polak JM (1999) Cytokine-induced prostaglandin E2 synthesis and cycloxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274: 1776
23. 23. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T (1995) Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 270: 24965
24. 24. Jarvis WD, Fornari FA Jr, Browning JL, Gewirtz DA, Kolesnick RN, Grant S (1994) Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 269: 31685
25. 25. Jong D de, Prins FA, Mason DY, Reed JC, Ommen GB van, Kluin PM (1994) Subcellular localization of the Bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54: 256
26. 26. Kelley DJ, Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Ramonetti JT, Dannenberg AJ (1997) Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells. Carcinogenesis 18: 795
27. 27. Kim Y, Fischer SM (1998) Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem 273: 27686
28. 28. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL, Prescott SM (1996) Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A 93: 4816
29. 29. Liu X-H, Rose DP (1997) Involvement of protein kinase C in COX-2 expression, activation, and subcellular translocation in a human breast cancer cell line. Proc Am Assoc Cancer Res 38: A4164
30. 30. Liu XH, Yao S, Kirschenbaum A, Levine AC (1998) NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates Bcl-2 expression in LNCaP cells. Cancer Res 58: 4245
31. 31. Lucas M, Sanchez-Margalet V (1995) Protein kinase C involvement in apoptosis. Gen Pharmacol 26: 881
32. 32. Maier JA, Ragnotti G (1993) An oligomer targeted against protein kinase C alpha prevents interleukin-1 alpha induction of cyclooxygenase expression in human endothelial cells. Exp Cell Res 205: 52
33. 33. Masferrer JL, Settle S, Zweifel BS, Edwards DA, Ornberg RL, Raz A, Seibert K (1998) Cyclooxygenase-2 inhibitors as novel antiangiogenic agents. Proc Am Assoc Cancer Res 39: A1855
34. 34. McHugh M, Cheng Y-C (1979) Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 254: 11312
35. 35. Miller BW, Baier LD, Morrison AR (1997) Overexpression of protein kinase C-zeta isoform increases cyclooxygenase-2 and inducible nitric oxide synthase. Am J Physiol 273: C130
36. 36. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, Smith WL (1995) Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902
37. 37. Motoyama T, Watanabe H (1983) Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice. Gann 74: 679
38. 38. Mullerdecker K, Koppschneider A, Marks F, Seibert K, Furstenberger G (1998) Localization of prostaglandin h synthase isoenzymes in murine epidermal tumors - suppression of skin tumor promotion by inhibition of prostaglandin h synthase-2. Mol Carcinog 23: 36
39. 39. Nabeya Y, Loganzo F Jr, Maslak P, Lai L, Oliveira AR de, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP (1995) The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int J Cancer 64: 37
40. 40. Newton R, Seybold J, Kuitert LM, Bergmann M, Barnes PJ (1998) Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273: 32312
41. 41. Nokihara H, Nishioka Y, Shinohara T, Yanagawa H, Sone S (1999) Critical role of cyclooxygenase-2 in sensitivity of human lung cancer cells to anticancer agents. Proc Am Assoc Cancer Res 40: A2824
42. 42. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T (1994) Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 269: 11769
43. 43. Ristimaki A, Narko K, Hla T (1996) Down-regulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318: 325
44. 44. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57: 1276
45. 45. Rosen KM, Villa-Komaroff L (1990) An alternative method for visualization of RNA in formaldehyde agarose gels. Focus 12: 23
46. 46. Rzymkiewicz DM, Tetsuka T, Daphna-Iken D, Srivastava S, Morrison AR (1996) Interleukin-1 beta activates protein kinase C zeta in renal mesangial cells. Potential role in prostaglandin E2 up-regulation. J Biol Chem 271: 17241
47. 47. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York
48. 48. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M (1998) Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 274: G1061
49. 49. Schwartz GK, Jiang J, Kelsen D, Albino AP (1993) Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 85: 402
50. 50. Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Kelsen DP, Fuks Z, Albino AP (1995) Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J Natl Cancer Inst 87: 1394
51. 51. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362
52. 52. Simonson MS, Wolfe JA, Konieczkowski M, Sedor JR, Dunn MJ (1991) Regulation of prostaglandin endoperoxide synthase gene expression in cultured rat mesangial cells: induction by serum via a protein kinase-C-dependent mechanism. Mol Endocrinol 5: 441
53. 53. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157
54. 54. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ (1996) Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56: 4424
55. 55. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273: 21875
56. 56. Tetsuka T, Baier LD, Morrison AR (1996) Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells. Evidence for post-transcriptional regulation. J Biol Chem 271: 11689
57. 57. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493
58. 58. Tsujii M, Kawano S, DuBois RN (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 94: 3336
59. 59. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells [published erratum appears in Cell (1998) 94(2): following 271]. Cell 93: 705
60. 60. Tucker ON, Dannenberg AJ, Yang FK, Zhang F, Teng LS, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ (1999) Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987
61. 61. Vezza R, Habib A, Li H, Lawson JA, FitzGerald GA (1996) Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation. J Biol Chem 271: 30028
62. 62. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111: 1134
63. 63. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 58: 2929
64. 64. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59: 198